Biotech Stocks Touching New Highs: Northwest Biotherapeutics (NASDAQ:NWBO), OncoGenex Pharmaceuticals (NASDAQ:OGXI), Emergent Biosolutions (NYSE:EBS), Xencor (NASDAQ:XNCR)

CRT Capital Thursday morning ratings report included a coverage initiation by analyst Arlinda Lee on Oncogenex Pharmaceuticals (NASDAQ: OGXI) with a Buy rating and price target of $20. OncoGenex Pharmaceuticals Inc (NASDAQ:OGXI) rose 8.88 percent to $13.85 yesterday on volume of 483,342million shares. The intra-day range of the stock was $12.61 to $13.95. OncoGenex Pharmaceuticals Inc (NASDAQ:OGXI) has a market capitalization of $203.70million.

Emergent Biosolutions Inc (NYSE:EBS) was downgraded byZacks from an “outperform” rating to a “neutral” rating in a research note issued on Monday. Emergent Biosolutions Inc (NYSE:EBS)’s stock on Mar 10, 2014 reported a increase of 1.15% to the closing price of $28.09. Its fifty two weeks range is $13.02 -$28.48. The total market capitalization recorded $1.02billion. The overall volume in the last trading session was 379,942.00million shares. In its share capital, EBS has 36.27million outstanding shares.

German health regulators have granted Northwest Biotherapeutics Inc (NASDAQ:NWBO) special permission to sell its experimental brain cancer drug, DCVax-L. Northwest Biotherapeutics, Inc (NASDAQ:NWBO) stock performance was 29.55% in last session and finished the day at $7.85. Traded volume was 6.18million shares in the last session and the average volume of the stock remained 913.66K shares. The beta of the stock remained 2.82. Northwest Biotherapeutics, Inc (NASDAQ:NWBO) insider ownership is 9.86%.

Xencor, Inc. (NASDAQ:XNCR) is a clinical-stage biopharmaceutical company. The Company focused on discovering and developing engineered monoclonal antibodies to treat severe and life-threatening diseases with unmet medical needs. On Monday, shares of Xencor Inc (NASDAQ:XNCR) advanced 4.40% to close the day at $13.05. Company return on investment (ROI) is 4.30% and its monthly performance is recorded as 42.31%.

Signup for free to be the first to receive exclusive free links. Now in your mailbox!
Join over 15,000 subscribers
Send me links

Your information will not be shared to anyone